IL6 and cancer: In cancer cells, a general activation of signaling pathways such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), STAT3, and nuclear factor κB (NF-kB) pathways happens, whereupon they promote the expression of IL-6, IL-10, GM-CSF and TGF-β, among others.